NCT05828095 A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV Status COMPLETED Phase PHASE1
NCT05769569 Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission Status WITHDRAWN Phase PHASE1
NCT05700630 Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia Status WITHDRAWN Phase PHASE1
NCT05668026 Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART Status RECRUITING Phase PHASE1/PHASE2
NCT05660980 Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age Status RECRUITING Phase PHASE1/PHASE2
NCT05652400 HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05642481 Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed Status COMPLETED Phase N/A
NCT05634265 Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study Status COMPLETED Phase NA
NCT05630885 A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV Status COMPLETED Phase PHASE2
NCT05606055 The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection Status COMPLETED Phase PHASE4
NCT05604209 Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART Status COMPLETED Phase PHASE1
NCT05601128 A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA Status COMPLETED Phase PHASE3
NCT05584397 Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART Status ENROLLING_BY_INVITATION Phase N/A
NCT05546242 Improving HIV-1 Control in Africa with Long Acting Antiretrovirals Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05516602 Improving HIV Prevention Among Adolescent Girls and Young Women (AGYW) in Uganda Status COMPLETED Phase NA
NCT05506605 Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance Status UNKNOWN Phase PHASE4